| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
BKL Stock Overview
Blackmores Limited develops, sells, and markets natural health products for humans and animals in Australia, New Zealand, Asia, China, and internationally.
Rewards
Risk Analysis
No risks detected for BKL from our risk checks.
Blackmores Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$80.20 |
| 52 Week High | AU$103.97 |
| 52 Week Low | AU$65.00 |
| Beta | 0.40 |
| 1 Month Change | 9.01% |
| 3 Month Change | 15.53% |
| 1 Year Change | 5.25% |
| 3 Year Change | 17.99% |
| 5 Year Change | -9.79% |
| Change since IPO | 2,816.36% |
Recent News & Updates
Capital Allocation Trends At Blackmores (ASX:BKL) Aren't Ideal
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to...
Is There An Opportunity With Blackmores Limited's (ASX:BKL) 34% Undervaluation?
Today we will run through one way of estimating the intrinsic value of Blackmores Limited ( ASX:BKL ) by taking the...
Shareholder Returns
| BKL | AU Personal Products | AU Market | |
|---|---|---|---|
| 7D | 2.2% | 1.6% | 1.8% |
| 1Y | 5.2% | -32.4% | -5.7% |
Return vs Industry: BKL exceeded the Australian Personal Products industry which returned -31.5% over the past year.
Return vs Market: BKL exceeded the Australian Market which returned -6.5% over the past year.
Price Volatility
| BKL volatility | |
|---|---|
| BKL Average Weekly Movement | 5.1% |
| Personal Products Industry Average Movement | 12.2% |
| Market Average Movement | 10.6% |
| 10% most volatile stocks in AU Market | 17.7% |
| 10% least volatile stocks in AU Market | 4.6% |
Stable Share Price: BKL is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: BKL's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1930 | 1,200 | Alastair Symington | https://www.blackmores.com.au |
Blackmores Limited develops, sells, and markets natural health products for humans and animals in Australia, New Zealand, Asia, China, and internationally. The company offers vitamins, and herbal and mineral nutritional supplements. It also provides products for various conditions related to arthritis, joints, bones, and muscles; brain health; cold, flu, and immunity; digestive health; energy and exercise; essentials; everyday health; and eye health.
Blackmores Limited Fundamentals Summary
| BKL fundamental statistics | |
|---|---|
| Market Cap | AU$1.56b |
| Earnings (TTM) | AU$30.16m |
| Revenue (TTM) | AU$619.38m |
51.7x
P/E Ratio2.5x
P/S RatioIs BKL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BKL income statement (TTM) | |
|---|---|
| Revenue | AU$619.38m |
| Cost of Revenue | AU$235.20m |
| Gross Profit | AU$384.18m |
| Other Expenses | AU$354.02m |
| Earnings | AU$30.16m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
Aug 18, 2022
| Earnings per share (EPS) | 1.55 |
| Gross Margin | 62.03% |
| Net Profit Margin | 4.87% |
| Debt/Equity Ratio | 0% |
How did BKL perform over the long term?
See historical performance and comparison